The DOI matches its Crossref record; 76 of the 76 references it cites were found in a registry or an index.
Substandard drugs: a potential crisis for public health
Open accessAbstract
Poor‐quality medicines present a serious public health problem, particularly in emerging economies and developing countries, and may have a significant impact on the national clinical and economic burden. Attention has largely focused on the increasing availability of deliberately falsified drugs, but substandard medicines are also reaching patients because of poor manufacturing and quality‐control practices in the production of genuine drugs (either branded or generic). Substandard medicines are widespread and represent a threat to health because they can inadvertently lead to healthcare failures, such as antibiotic resistance and the spread of disease within a community, as well as death or additional illness in individuals. This article reviews the different aspects of substandard drug formulation that can occur (for example, pharmacological variability between drug batches or between generic and originator drugs, incorrect drug quantity and presence of impurities). The possible means of addressing substandard manufacturing practices are also discussed. A concerted effort is required on the part of governments, drug manufacturers, charities and healthcare providers to ensure that only drugs of acceptable quality reach the patient.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Antibiotic resistance threats in the United States, 2019
(U.S.), C. F. D. C. A. P. (2019) · doi:10.15620/cdc:82532 · Cited by 5,782
Evidence of Artemisinin-Resistant Malaria in Western Cambodia
Noedl, H., Se, Y., Schaecher, K., Smith, B. L., Socheat, D., & Fukuda, M. M. (2008) · New England Journal of Medicine · doi:10.1056/nejmc0805011 · Cited by 1,785
THE UNITED STATES PHARMACOPEIAL CONVENTION
Hirschfelder, A. D. (1930) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1930.02720030050030 · Cited by 1,006
Emergence of artemisinin-resistant malaria on the western border of Thailand: a longitudinal study
Phyo, A. P., Nkhoma, S., Stepniewska, K., Ashley, E. A., Nair, S., McGready, R., ler Moo, C., Al-Saai, S., Dondorp, A. M., Lwin, K. M., et al. (2012) · The Lancet · doi:10.1016/s0140-6736(12)60484-x · Cited by 924
Review of corruption in the health sector: theory, methods and interventions
Vian, T. (2007) · Health Policy and Planning · doi:10.1093/heapol/czm048 · Cited by 422
Substandard medicines in resource‐poor settings: a problem that can no longer be ignored
Caudron, J. ‐., Ford, N., Henkens, M., Macé, C., Kiddle‐Monroe, R., & Pinel, J. (2008) · Tropical Medicine & International Health · doi:10.1111/j.1365-3156.2008.02106.x · Cited by 332
The Global Threat of Counterfeit Drugs: Why Industry and Governments Must Communicate the Dangers
Cockburn, R., Newton, P. N., Agyarko, E. K., Akunyili, D., & White, N. J. (2005) · PLoS Medicine · doi:10.1371/journal.pmed.0020100 · Cited by 330
Outbreak of Adverse Reactions Associated with Contaminated Heparin
Blossom, D. B., Kallen, A. J., Patel, P. R., Elward, A., Robinson, L., Gao, G., Langer, R., Perkins, K. M., Jaeger, J. L., Kurkjian, K. M., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0806450 · Cited by 282
Counterfeit or substandard antimicrobial drugs: a review of the scientific evidence
Kelesidis, T., Kelesidis, I., Rafailidis, P. I., & Falagas, M. E. (2007) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkm109 · Cited by 242
Dondorp, A. M., Newton, P. N., Mayxay, M., Van Damme, W., Smithuis, F. M., Yeung, S., Petit, A., Lynam, A. J., Johnson, A., Hien, T. T., et al. (2004) · Tropical Medicine & International Health · doi:10.1111/j.1365-3156.2004.01342.x · Cited by 240
Elixirs, Diluents, and the Passage of the 1938 Federal Food, Drug and Cosmetic Act
Wax, P. M. (1995) · Annals of Internal Medicine · doi:10.7326/0003-4819-122-6-199503150-00009 · Cited by 236
Pharmacopoeial quality of drugs supplied by Nigerian pharmacies
Taylor, R., Shakoor, O., Behrens, R., Everard, M., Low, A., Wangboonskul, J., Reid, R., & Kolawole, J. (2001) · The Lancet · doi:10.1016/s0140-6736(00)05065-0 · Cited by 221
(2002) · Choice Reviews Online · doi:10.5860/choice.40-1804 · Cited by 219
Countering the Problem of Falsified and Substandard Drugs
Committee on Understanding the Global Public Health Implications of Substandard, F., Board on Global Health, & Institute of Medicine (2013) · National Academies Press eBooks · doi:10.17226/18272 · Cited by 209
Fungal Infections Associated with Contaminated Methylprednisolone in Tennessee
Kainer, M. A., Reagan, D. R., Nguyen, D. B., Wiese, A. D., Wise, M. E., Ward, J., Park, B. J., Kanago, M. L., Baumblatt, J., Schaefer, M. K., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1212972 · Cited by 209
Hyperparasitaemia and low dosing are an important source of anti-malarial drug resistance
White, N. J., Pongtavornpinyo, W., Maude, R. J., Saralamba, S., Aguas, R., Stepniewska, K., Lee, S. J., Dondorp, A. M., White, L. J., & Day, N. P. (2009) · Malaria Journal · doi:10.1186/1475-2875-8-253 · Cited by 194
Schep, L. J., Slaughter, R. J., Temple, W. A., & Beasley, D. M. G. (2009) · Clinical Toxicology · doi:10.1080/15563650903086444 · Cited by 192
Multidrug-resistant tuberculosis: epidemiology, risk factors and case finding
Luna, J. A. C., & Antônio, J. (2010) · Cited by 190
Manslaughter by Fake Artesunate in Asia—Will Africa Be Next?
Newton, P. N., McGready, R., Fernandez, F., Green, M. D., Sunjio, M., Bruneton, C., Phanouvong, S., Millet, P., Whitty, C. J. M., Talisuna, A. O., et al. (2006) · PLoS Medicine · doi:10.1371/journal.pmed.0030197 · Cited by 184
Elixirs, Diluents, and the Passage the 1938 Federal Food, Drug and Cosmetic Act
&NA; (1996) · Journal of Occupational & Environmental Medicine · doi:10.1097/00043764-199607000-00005 · Cited by 173
Anthelmintic resistance in human helminths: a review
Geerts, S., & Gryseels, B. (2001) · Tropical Medicine & International Health · doi:10.1046/j.1365-3156.2001.00774.x · Cited by 163
Antimalarial Drug Quality in the Most Severely Malarious Parts of Africa – A Six Country Study
Bate, R., Coticelli, P., Tren, R., & Attaran, A. (2008) · PLoS ONE · doi:10.1371/journal.pone.0002132 · Cited by 161
How to achieve international action on falsified and substandard medicines
Attaran, A., Barry, D., Basheer, S., Bate, R., Benton, D., Chauvin, J., Garrett, L., Kickbusch, I., Köhler, J. C., Midha, K. K., et al. (2012) · BMJ · doi:10.1136/bmj.e7381 · Cited by 161
Molecular epidemiology of malaria in Cameroon
Tahar, R., & Basco, L. K. (2007) · Acta Tropica · doi:10.1016/j.actatropica.2007.04.008 · Cited by 159
Multidrug-resistant tuberculosis: epidemiology, risk factors and case finding.
Luna, J. A. C. (2010) · PubMed · Cited by 151
Gardner, L. K., & Lawrence, G. D. (1993) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf00029a001 · Cited by 150
Poor quality vital anti-malarials in Africa - an urgent neglected public health priority
Newton, P. N., Green, M. D., Mildenhall, D. C., Plançon, A., Nettey, H., Nyadong, L., Hostetler, D. M., Swamidoss, I., Harris, G. A., Powell, K., et al. (2011) · Malaria Journal · doi:10.1186/1475-2875-10-352 · Cited by 140
Onwujekwe, O. E., Kaur, H., Dike, N., Shu, E. N., Uzochukwu, B. S. C., Hanson, K., Okoye, V., & Okonkwo, P. O. (2009) · Malaria Journal · doi:10.1186/1475-2875-8-22 · Cited by 123
Counterfeit and substandard antimalarial drugs in Cambodia
Lon, C., Tsuyuoka, R., Phanouvong, S., Nivanna, N., Socheat, D., Sokhan, C., Blum, N., Christophel, E. M., & Smine, A. (2006) · Transactions of the Royal Society of Tropical Medicine and Hygiene · doi:10.1016/j.trstmh.2006.01.003 · Cited by 114
Counterfeit phosphodiesterase type 5 inhibitors pose significant safety risks
Jackson, G., Arver, S., Banks, I., & Stecher, V. J. (2010) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2009.02328.x · Cited by 112
Basco, L. K. (2004) · American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.2004.70.245 · Cited by 107
Newton, P. N., White, N. J., Rozendaal, J. A., & Green, M. D. (2002) · BMJ · doi:10.1136/bmj.324.7341.800 · Cited by 102
Ricci, C., Nyadong, L., Yang, F., Fernández, F. M., Brown, C. D., Newton, P. N., & Kazarian, S. G. (2008) · Analytica Chimica Acta · doi:10.1016/j.aca.2008.06.007 · Cited by 101
Pharmacokinetic and pharmaceutic interaction between digoxin and Cremophor RH40
Tayrouz, Y., Ding, R., Burhenne, J., Riedel, K., Weiß, J., Hoppe‐Tichy, T., Haefeli, W. E., & Mikus, G. (2003) · Clinical Pharmacology & Therapeutics · doi:10.1016/s0009-9236(03)00059-6 · Cited by 94
Gomez, Y., Adams, E., & Hoogmartens, J. (2003) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/s0731-7085(03)00533-8 · Cited by 94
Pilot Study of Essential Drug Quality in Two Major Cities in India
Bate, R., Tren, R., Mooney, L., Hess, K., Mitra, B. S., Debroy, B., & Attaran, A. (2009) · PLoS ONE · doi:10.1371/journal.pone.0006003 · Cited by 91
Fernández, F. M., Hostetler, D. M., Powell, K., Kaur, H., Green, M. D., Mildenhall, D. C., & Newton, P. N. (2010) · The Analyst · doi:10.1039/c0an00627k · Cited by 88
Hajjou, M., Qin, Y., Bradby, S., Bempong, D. K., & Lukulay, P. H. (2012) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/j.jpba.2012.09.016 · Cited by 87
Antimalarial drug quality in Africa
Amin, A. A., & Kokwaro, G. O. (2007) · Journal of Clinical Pharmacy and Therapeutics · doi:10.1111/j.1365-2710.2007.00847.x · Cited by 84
A Nationwide Survey of the Quality of Antimalarials in Retail Outlets in Tanzania
Kaur, H., Goodman, C. A., Thompson, E., Thompson, K., Masanja, I. M., Kachur, S. P., & Abdulla, S. (2008) · PLoS ONE · doi:10.1371/journal.pone.0003403 · Cited by 76
Transparency in Nigeria's public pharmaceutical sector: perceptions from policy makers
Garuba, H. A., Köhler, J. C., & Huisman, A. M. (2009) · Globalization and Health · doi:10.1186/1744-8603-5-14 · Cited by 74
Substandard tuberculosis drugs on the global market and their simple detection.
Laserson, K. F., As, K., Kenyon, T. A., Layloff, T. P., & Nj, B. (2001) · PubMed · Cited by 73
Hadi, U., van den Broek, P., Kolopaking, E. P., Zairina, N., Gardjito, W., Gyssens, I. C., & the Study Group 'Antimicrobial Resistance in Indonesia: Prevalence and Prevention' (AMRIN) (2010) · BMC Infectious Diseases · doi:10.1186/1471-2334-10-203 · Cited by 72
Multisource drug policies in Latin America: survey of 10 countries.
Homedes, N., & Ugalde, A. (2005) · PubMed · Cited by 71
“Inactive” excipients such as Cremophor can affect in vivo drug disposition
Wandel, C., Kim, R. B., & Stein, C. M. (2003) · Clinical Pharmacology & Therapeutics · doi:10.1016/s0009-9236(03)00010-9 · Cited by 70
Substandard anti-malarial drugs in Burkina Faso
Tipke, M., Diallo, S., Coulibaly, B., Störzinger, D., Hoppe‐Tichy, T., Sié, A., & Müller, O. (2008) · Malaria Journal · doi:10.1186/1475-2875-7-95 · Cited by 69
Sengaloundeth, S., Green, M. D., Fernández, F. M., Manolin, O., Phommavong, K., Insixiengmay, V., Hampton, C. Y., Nyadong, L., Mildenhall, D. C., Hostetler, D. M., et al. (2009) · Malaria Journal · doi:10.1186/1475-2875-8-172 · Cited by 68
Minzi, O., Moshi, M. J., Shewiyo, D. H., Massele, A. Y., Tomson, G. B., Ericsson, Ö., & Gustafsson, L. L. (2003) · Journal of Clinical Pharmacy and Therapeutics · doi:10.1046/j.1365-2710.2003.00470.x · Cited by 67
Green, M. D., Mount, D. L., & Wirtz, R. A. (2001) · Tropical Medicine & International Health · doi:10.1046/j.1365-3156.2001.00793.x · Cited by 61
Epidemic of Plasmodium falciparum Malaria Involving Substandard Antimalarial Drugs, Pakistan, 2003
Leslie, T. J., Kaur, H., Mohammed, N., Kolaczinski, K., Ord, R. L., & Rowland, M. (2009) · Emerging infectious diseases · doi:10.3201/eid1511.090886 · Cited by 59
The quality of sulphadoxine-pyrimethamine and amodiaquine products in the Kenyan retail sector
Amin, A. A., Snow, R. W., & Kokwaro, G. O. (2005) · Journal of Clinical Pharmacy and Therapeutics · doi:10.1111/j.1365-2710.2005.00685.x · Cited by 57
The quality of drugs in private pharmacies in Lao PDR: a repeat study in 1997 and 1999
Syhakhang, L., Lundborg, C. S., Lindgren, B., & Tomson, G. (2004) · Pharmacy World & Science · doi:10.1007/s11096-004-0558-3 · Cited by 52
In vitro evaluation of the quality of essential drugs on the Tanzanian market
Risha, P., Shewiyo, D. H., Msami, A., et al. (2002) · Tropical Medicine & International Health · doi:10.1046/j.1365-3156.2002.00937.x · Cited by 52
Substandard and counterfeit medicines.
Rassool, G. H. (2004) · PubMed · Cited by 52
Blossom, D. B., Noble-Wang, J., Su, J., Pur, S., Chemaly, R., Shams, A., Jensen, B., Pascoe, N., Gullion, J., Casey, E., et al. (2009) · Archives of Internal Medicine · doi:10.1001/archinternmed.2009.290 · Cited by 47
Risha, P., Msuya, Z., Clark, M., Johnson, K. W., Ndomondo-Sigonda, M., & Layloff, T. P. (2008) · Health Policy · doi:10.1016/j.healthpol.2007.12.010 · Cited by 46
Keoluangkhot, V., Green, M. D., Nyadong, L., Fernández, F. M., Mayxay, M., & Newton, P. N. (2008) · American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.2008.78.552 · Cited by 45
Comparative analysis of the activity and content of different streptokinase preparations
Hermentin, P., Cuesta-Linker, T., Weisse, J., Schmidt, K., Knorst, M., Scheld, M., & Thimme, M. (2005) · European Heart Journal · doi:10.1093/eurheartj/ehi093 · Cited by 44
Phake: the deadly world of falsified and substandard medicines
(2014) · Choice Reviews Online · doi:10.5860/choice.52-0301 · Cited by 40
The pharmaceutical death-ride of dihydroartemisinin
Jansen, F. H. (2010) · Malaria Journal · doi:10.1186/1475-2875-9-212 · Cited by 39
Packaging and Labeling of Pharmaceutical Products Obtained from the Internet
Veronin, M. A. (2011) · Journal of Medical Internet Research · doi:10.2196/jmir.1441 · Cited by 35
Ensuring Safe Foods and Medical Products Through Stronger Regulatory Systems Abroad
Board on Global Health, & Board on Health Sciences Policy (2012) · National Academies Press eBooks · doi:10.17226/13296 · Cited by 33
Quality of amoxicillin formulations in some Arab countries
Kyriacos, S., Mroueh, M. A., Chahine, R. P., & Khouzam, O. (2008) · Journal of Clinical Pharmacy and Therapeutics · doi:10.1111/j.1365-2710.2008.00926.x · Cited by 33
Twagirumukiza, M., Cosijns, A., Pringels, E., Remon, J. P., Vervaet, C., & Bortel, L. M. V. (2009) · American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.2009.09-0109 · Cited by 32
Quality Control of Antibiotics Before the Implementation of an STD Program in Northern Myanmar
Prazuck, T., Falconi, I., Morineau, G., BRICARD-PACAUD, V., Lecomte, A., & Ballereau, F. (2002) · Sexually Transmitted Diseases · doi:10.1097/00007435-200211000-00002 · Cited by 30
The quality of antimalarials available in Yemen
Abdo-Rabbo, A., Bassili, A., & Atta, H. (2005) · Malaria Journal · doi:10.1186/1475-2875-4-28 · Cited by 28
Mertès, P., Bazin, A., Alla, F., Bienvenu, J., Caldani, C., Lamy, B., Laroche, D., Floris, M., Py, J.-Y., Rebibo, D., et al. (2011) · PubMed · Cited by 27
The fight against fake drugs by NAFDAC in Nigeria
Chinwendu, O. (2010) · Cited by 24
Ofori-Kwakye, K., & El-Duah, M. (2012) · Journal of Vector Borne Diseases · doi:10.4103/0972-9062.213452 · Cited by 23
Pharmaceutical quality of generic isotretinoin products, compared with Roaccutane
Taylor, P. W., & Keenan, M. H. J. (2006) · Current Medical Research and Opinion · doi:10.1185/030079906x96326 · Cited by 19
The WWARN Antimalarial Quality Surveyor
Tabernero, P., & Newton, P. N. (2012) · Pathogens and Global Health · doi:10.1179/204777312x13419245939520 · Cited by 15
Comparison of two in vitro sensitivity tests for Plasmodium falciparum.
Chaijaroenkul, W., Tippawangkosol, P., Kuesap, J., Congpuong, K., Ruenweerayut, R., Suwandittakul, N., Songthammawat, D., & Na-Bangchang, K. (2006) · PubMed · Cited by 14
Tadeg, H., & Berhane, Y. (2012) · PubMed · Cited by 11
Okumura, J., Taga, M., Tey, S., Kataoka, Y., Nam, N. H., & Kimura, K. (2010) · Tropical Medicine & International Health · doi:10.1111/j.1365-3156.2010.02627.x · Cited by 10
Quality and Behavior of Glimepiride Generics Versus Amaryl Under Stressed Conditions
Attorrese, G., & Massi‐Benedetti, M. (2007) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2006.0029 · Cited by 8
An Herbal Remedy for Impotence: More Than Was Bargained For
Kenyon, S. L., Button, J., Perella, P., McKeown, D. A., Holt, D. W., & Chem, E. (2006) · The Journal of Clinical Pharmacology · doi:10.1177/0091270006292630 · Cited by 4
Self-citation
Cited by
Essential medicines for universal health coverage
Wirtz, V. J., Hogerzeil, H. V., Gray, A. L., Bigdeli, M., de Joncheere, C. P., Ewen, M. A., Gyansa-Lutterodt, M., Jing, S., Luiza, V. L., Mbindyo, R. M., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(16)31599-9 · Cited by 661
Antibiotic stewardship in low- and middle-income countries: the same but different?
Cox, J. A., Vlieghe, E., Mendelson, M., Wertheim, H., Ndegwa, L., Villegas, M. V., Gould, I., & Levy Hara, G. (2017) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2017.07.010 · Cited by 529
Anti-corruption, transparency and accountability in health: concepts, frameworks, and approaches
Vian, T. (2020) · Global Health Action · doi:10.1080/16549716.2019.1694744 · Cited by 249
Hambisa, S., Belew, S., & Suleman, S. (2019) · Drug Design Development and Therapy · doi:10.2147/dddt.s189524 · Cited by 30
“Furthermore, the consumption of poor quality drugs is characterized by numerous consequences including treatment failure, drug resistance, increased morbidity and mortality.(14) Similarly, the absence of strong drug regulatory authorities and poor quality control practices in some countries have resulted in the availa…”
Background
Metadata
- Authors
- Johnston, A., & Holt, D. W.
- Venue
- British Journal of Clinical Pharmacology
- Publisher
- Wiley
- Published
- 2014-07-21
- Volume
- 78
- Issue
- 2
- Pages
- 218-243
- ISSN
- 0306-5251 (ISSN-L)
- 1365-2125
- OpenAlex
- W1480324092
- Cited by
- 270
- References
- 76
- FWCI
- 6.93
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.